Advertisement

Topics

Sunovion Announces FDA Acceptance for Review of New Drug Application for Dasotraline for the ...

06:06 EST 10 Nov 2017 | BioMedReports - Blog

Sunovion Pharmaceuticals Inc.
Kristina Coppola, 508-787-4368
Associate Director, Portfolio Communications
kristina.coppola@sunovion.com

Read more...

Original Article: Sunovion Announces FDA Acceptance for Review of New Drug Application for Dasotraline for the ...

NEXT ARTICLE

More From BioPortfolio on "Sunovion Announces FDA Acceptance for Review of New Drug Application for Dasotraline for the ..."

Advertisement
Quick Search
Advertisement
Advertisement